HomeCompareRCDTF vs BTI

RCDTF vs BTI: Dividend Comparison 2026

RCDTF yields 2.77% · BTI yields 5.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RCDTF wins by $14.8K in total portfolio value· pulled ahead in Year 7
10 years
RCDTF
RCDTF
● Live price
2.77%
Share price
$56.95
Annual div
$1.58
5Y div CAGR
32%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$52.6K
Annual income
$9,708.55
Full RCDTF calculator →
BTI
BTI
● Live price
5.40%
Share price
$58.26
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.8K
Annual income
$2,802.29
Full BTI calculator →

Portfolio growth — RCDTF vs BTI

📍 RCDTF pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRCDTFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RCDTF + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RCDTF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RCDTF
Annual income on $10K today (after 15% tax)
$235.82/yr
After 10yr DRIP, annual income (after tax)
$8,252.27/yr
BTI
Annual income on $10K today (after 15% tax)
$459.05/yr
After 10yr DRIP, annual income (after tax)
$2,381.95/yr
At 15% tax rate, RCDTF beats the other by $5,870.32/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RCDTF + BTI for your $10,000?

RCDTF: 50%BTI: 50%
100% BTI50/50100% RCDTF
Portfolio after 10yr
$45.2K
Annual income
$6,255.42/yr
Blended yield
13.84%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

RCDTF
Analyst Ratings
2
Hold
1
Sell
Consensus: Hold
Altman Z
3.4
Piotroski
5/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.3% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RCDTF buys
0
BTI buys
0
No recent congressional trades found for RCDTF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRCDTFBTI
Forward yield2.77%5.40%
Annual dividend / share$1.58$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR32%11.3%
Portfolio after 10y$52.6K$37.8K
Annual income after 10y$9,708.55$2,802.29
Total dividends collected$28.6K$14.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldBuy

Year-by-year: RCDTF vs BTI ($10,000, DRIP)

YearRCDTF PortfolioRCDTF Income/yrBTI PortfolioBTI Income/yrGap
1$11,066$366.22$11,301$601.08$235.00BTI
2$12,341$499.95$12,799$706.58$458.00BTI
3$13,892$687.80$14,527$832.38$635.00BTI
4$15,820$955.18$16,527$982.75$707.00BTI
5$18,269$1,341.86$18,846$1,162.95$577.00BTI
6$21,460$1,911.67$21,545$1,379.49$85.00BTI
7← crossover$25,732$2,770.17$24,694$1,640.41+$1.0KRCDTF
8$31,631$4,097.76$28,378$1,955.69+$3.3KRCDTF
9$40,060$6,214.06$32,702$2,337.79+$7.4KRCDTF
10$52,572$9,708.55$37,794$2,802.29+$14.8KRCDTF

RCDTF vs BTI: Complete Analysis 2026

RCDTFStock

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.

Full RCDTF Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this RCDTF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RCDTF vs SCHDRCDTF vs JEPIRCDTF vs ORCDTF vs KORCDTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.